Literature DB >> 9323478

Sensitivity of microscopy versus enzyme immunoassay in the laboratory diagnosis of giardiasis.

T G Mank1, J O Zaat, A M Deelder, J T van Eijk, A M Polderman.   

Abstract

The substitution of enzyme immunoassay (EIA) techniques for microscopy as a screening tool for Giardia lamblia infection was assessed. Paired stool samples obtained within a ten-day period from 366 patients with persistent diarrhea were examined by microscopy. In addition, two commercially available Giardia lamblia-specific EIAs were performed. Compared with microscopy, EIA for copro-antigen detection was more sensitive, based on examination of either one or two stool samples. Repeated examinations increased the number of cases detected, more so for microscopy than EIA. The negative predictive values of the two EIAs performed on the first stool sample were 98.7% and 97.8%. The results show that EIA for detection of copro-antigens in a single stool sample may be almost as sensitive for identifying Giardia infection as repeated microscopy on two sequential stool samples.

Entities:  

Mesh:

Year:  1997        PMID: 9323478     DOI: 10.1007/BF02447929

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   5.103


  14 in total

1.  The experimental transmission of human intestinal protozoan parasites. II. Giardia lamblia cysts given in capsules.

Authors:  R C RENDTORFF
Journal:  Am J Hyg       Date:  1954-03

Review 2.  The clinical and laboratory diagnosis of giardiasis.

Authors:  J A Burke
Journal:  CRC Crit Rev Clin Lab Sci       Date:  1977-06

3.  Numbers of Giardia in the feces of infected children.

Authors:  M Danciger; M Lopez
Journal:  Am J Trop Med Hyg       Date:  1975-03       Impact factor: 2.345

4.  Multiple stool examinations for ova and parasites and rate of false-negative results.

Authors:  H Marti; J C Koella
Journal:  J Clin Microbiol       Date:  1993-11       Impact factor: 5.948

5.  Stool diagnosis of giardiasis using a commercially available enzyme immunoassay to detect Giardia-specific antigen 65 (GSA 65).

Authors:  J D Rosoff; C A Sanders; S S Sonnad; P R De Lay; W K Hadley; F F Vincenzi; D M Yajko; P D O'Hanley
Journal:  J Clin Microbiol       Date:  1989-09       Impact factor: 5.948

6.  Giardia antigen detection in patients with chronic gastrointestinal disturbances.

Authors:  C L Chappell; C C Matson
Journal:  J Fam Pract       Date:  1992-07       Impact factor: 0.493

7.  Experimental human infections with Giardia lamblia.

Authors:  T E Nash; D A Herrington; G A Losonsky; M M Levine
Journal:  J Infect Dis       Date:  1987-12       Impact factor: 5.226

8.  A field and laboratory evaluation of a commercial ELISA for the detection of Giardia coproantigens in humans and dogs.

Authors:  R M Hopkins; P Deplazes; B P Meloni; J A Reynoldson; R C Thompson
Journal:  Trans R Soc Trop Med Hyg       Date:  1993 Jan-Feb       Impact factor: 2.184

9.  Comparison of fresh versus sodium acetate acetic acid formalin preserved stool specimens for diagnosis of intestinal protozoal infections.

Authors:  T G Mank; J O Zaat; J Blotkamp; A M Polderman
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995-12       Impact factor: 3.267

10.  Prepatency of giardiasis.

Authors:  A M Jokipii; L Jokipii
Journal:  Lancet       Date:  1977-05-21       Impact factor: 79.321

View more
  24 in total

1.  Triple Faeces Test: an effective tool for detection of intestinal parasites in routine clinical practice.

Authors:  T van Gool; R Weijts; E Lommerse; T G Mank
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-05-08       Impact factor: 3.267

2.  Guidelines for the investigation of chronic diarrhoea, 2nd edition.

Authors:  P D Thomas; A Forbes; J Green; P Howdle; R Long; R Playford; M Sheridan; R Stevens; R Valori; J Walters; G M Addison; P Hill; G Brydon
Journal:  Gut       Date:  2003-07       Impact factor: 23.059

Review 3.  WITHDRAWN: Drugs for treating giardiasis.

Authors:  J O M Zaat; T H G Mank; W J J Assendelft
Journal:  Cochrane Database Syst Rev       Date:  2007-07-18

4.  Use of an enzyme immunoassay does not eliminate the need to analyze multiple stool specimens for sensitive detection of Giardia lamblia.

Authors:  K L Hanson; C P Cartwright
Journal:  J Clin Microbiol       Date:  2001-02       Impact factor: 5.948

5.  Etiology of acute gastroenteritis in children requiring hospitalization in the Netherlands.

Authors:  I H M Friesema; R F de Boer; E Duizer; L M Kortbeek; D W Notermans; O F Norbruis; D D L Bezemer; H van Heerbeek; R N J van Andel; J G van Enk; P L A Fraaij; M P G Koopmans; A M D Kooistra-Smid; Y T H P van Duynhoven
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-07-03       Impact factor: 3.267

Review 6.  Immune response to Giardia duodenalis.

Authors:  G Faubert
Journal:  Clin Microbiol Rev       Date:  2000-01       Impact factor: 26.132

7.  Evaluation of an inhouse rapid ELISA test for detection of giardia in domestic sheep (Ovis aries).

Authors:  Jolaine M Wilson; F Claire Hankenson
Journal:  J Am Assoc Lab Anim Sci       Date:  2010-11       Impact factor: 1.232

8.  Prevalence and associated risk factors of Giardia duodenalis infection among school-going children in Nepal.

Authors:  Sarmila Tandukar; Jeevan B Sherchand; Jia Xue; Sital Uprety; Samendra P Sherchan; Dinesh Bhandari; Bikash Malla; Rajani Ghaju Shrestha; Laxmi Parajuli; Shristi Poudel; Ashmita Dhital; Eiji Haramoto
Journal:  Parasitol Res       Date:  2017-12-07       Impact factor: 2.289

9.  Evaluation of three commercial assays for detection of Giardia and Cryptosporidium organisms in fecal specimens.

Authors:  Stephanie P Johnston; Melissa M Ballard; Michael J Beach; Louise Causer; Patricia P Wilkins
Journal:  J Clin Microbiol       Date:  2003-02       Impact factor: 5.948

10.  Molecular seasonality of Giardia lamblia in a cohort of Egyptian children: a circannual pattern.

Authors:  Mousa A M Ismail; Dina M H El-Akkad; Enas M A Rizk; Hala M El-Askary; Ayman A El-Badry
Journal:  Parasitol Res       Date:  2016-07-23       Impact factor: 2.289

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.